Publication details
Naše zkušenosti s léčbou bexarotenem u kožních T-lymfomů
| Title in English | Our experience with bexarotene treatment of cutaneous T-cell lymphoma |
|---|---|
| Authors | |
| Year of publication | 2011 |
| Type | Article in Periodical |
| Magazine / Source | Dermatologie pro praxi |
| MU Faculty or unit | |
| Citation | |
| Field | Dermatovenerology |
| Keywords | primary cutaneous lymphoma; staging; prognosis; therapy; bexarotene |
| Description | Primary cutaneous lymphomas form a heterogeneous group of diseases which, at the time of stating diagnosis, affect only skin and have no obvious effect on lymphatic nodes or visceral organs. There is no causal therapy of cutaneous T-cell lymphoma. The aim of treatment is to provide the longest possible disease remission, sustain the patients’ life quality and prolong their lives as such. Bexarotene is an effective and relatively safe preparation meant for treating aggressive cutaneous T-cell lymphoma as well as developed forms of mycosis fungoides. |